BioWorld-International-2010-10-06
One GIANT Step for Mankind: New Genes for Height Control
Zealand's Lixisenatide Hits Mark in Phase III Combo Trial
Lixisenatide, the Type II diabetes molecule discovered by Zealand Pharma A/S, met the primary endpoint in the first Phase III combination trial. (BioWorld International)

